Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
- Alternative title
-
Die Vorhersage von triple-negativem Brustkrebs mithilfe von brustkrebsassoziierten Einzelnukleotid-Polymorphismen und verschiedenen Variablenselektionsmethoden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods ; volume:77 ; number:06 ; year:2017 ; pages:667-678
Geburtshilfe und Frauenheilkunde ; 77, Heft 06 (2017), 667-678
- Contributor
-
Häberle, Lothar
Hein, Alexander
Rübner, Matthias
Schneider, Michael
Ekici, Arif Bülent
Gass, Paul
Hartmann, Arndt
Schulz-Wendtland, Rüdiger
Beckmann, Matthias W.
Lo, Wing-Yee
Schroth, Werner
Brauch, Hiltrud
Fasching, Peter Andreas
Wunderle, Marius
- DOI
-
10.1055/s-0043-111602
- URN
-
urn:nbn:de:101:1-2018102912574303183844
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Häberle, Lothar
- Hein, Alexander
- Rübner, Matthias
- Schneider, Michael
- Ekici, Arif Bülent
- Gass, Paul
- Hartmann, Arndt
- Schulz-Wendtland, Rüdiger
- Beckmann, Matthias W.
- Lo, Wing-Yee
- Schroth, Werner
- Brauch, Hiltrud
- Fasching, Peter Andreas
- Wunderle, Marius
Other Objects (12)
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study